✦ LIBER ✦

Measuring the Consequences of Using Diverse Supplier Evaluation Teams: A Performance Frontier Perspective

✍ Scribed by Frank P. Buffa; Anthony D. Ross

Book ID: 118115680
Publisher: Wiley (John Wiley & Sons)
Year: 2011
Tongue: English
Weight: 346 KB
Volume: 32
Category: Article
ISSN: 0735-3766
DOI: 10.1111/j.2158-1592.2011.01005.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

On the use of the overlapping area matri

On the use of the overlapping area matrix for image segmentation evaluation: A survey and new performance measures

✍ Alberto Ortiz; Gabriel Oliver 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Prospective Evaluation of Beta-Blocker U

Prospective Evaluation of Beta-Blocker Use at the Time of Hospital Discharge as a Heart Failure Performance Measure: Results From OPTIMIZE-HF

✍ Gregg C. Fonarow; William T. Abraham; Nancy M. Albert; Wendy Gattis Stough; Miha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Evaluation of a training program for per

Evaluation of a training program for persons with SCI paraplegia using the Parastep®1 ambulation system: Part 1. Ambulation performance and anthropometric measures

✍ K.John Klose; Patrick L. Jacobs; James G. Broton; Rosalind S. Guest; Belinda M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 571 KB

Evaluating the serial use of the myelofi

Evaluating the serial use of the myelofibrosis symptom assessment form for measuring symptomatic improvement : Performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial

✍ Ruben A. Mesa; Hagop Kantarjian; Ayalew Tefferi; Amylou Dueck; Richard Levy; Kri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

## Abstract ## BACKGROUND: Symptomatic burden from constitutional symptoms, anemia, and splenomegaly‐related symptoms are common and morbidity inducing in patients with myelofibrosis (MF). The authors previously developed a MF‐specific instrument for capturing the burden of MF‐associated disease‐r